Patient and public involvement in health technology assessments: study protocol for a cross-sectional analysis


Por: Catalá-López F, Ganuza E, Colin C, Perna R, Hutton B, Nafria-Escalera B, Alonso-Arroyo A, Tejedor-Romero L, Turrini M, Sandonís-Camarero D, Lucas-Domínguez R, Ridao M, C Tricco A, Staniszewska S and Moher D

Publicada: 1 abr 2026 Ahead of Print: 1 abr 2026
Resumen:
Objective: Patient and public involvement (PPI) is an essential component of Health Technology Assessment (HTA), as it enhances the relevance and transparency of evaluation processes. Nevertheless, the scope of such involvement varies considerably across contexts, and empirical evidence on current practices within the National Health System remains limited. This study will examine the extent to which HTA reports incorporate PPI and how these practices are performed and described. Method: We will conduct a cross-sectional meta-research study of HTA reports produced by the Spanish Network of HTA Agencies (RedETS) between 2020 and 2026. Eligible reports will be identified through public repositories (https://redets.sanidad.gob.es/). A random sample of 150 reports will be selected. General and methodological characteristics, and PPI reporting practices will be extracted (by at least three researchers) from each HTA report using a standardised data extraction form. Descriptive analyses will be carried out to synthesise PPI reporting practices. Study registration: Open Science Framework (https://osf.io/k6e3q/). (c) 2026 SESPAS. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Filiaciones:
Catalá-López F:
 Institute of Public Goods and Policies (IPP), Centre for Human and Social Sciences, Spanish National Research Council (CSIC), Madrid, Spain

 Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

 Centre for Biomedical Research in Mental Health Network (CIBERSAM), Institute of Health Carlos III, Madrid, Spain

Ganuza E:
 Institute of Public Goods and Policies (IPP), Centre for Human and Social Sciences, Spanish National Research Council (CSIC), Madrid, Spain

Colin C:
 Patient Representative and General Coordinator, Phelan-McDermid Syndrome Association, Madrid, Spain

Perna R:
 Institute of Public Goods and Policies (IPP), Centre for Human and Social Sciences, Spanish National Research Council (CSIC), Madrid, Spain

Hutton B:
 Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

 School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Nafria-Escalera B:
 Patient Representative and Head of Patient Engagement in Research, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat (Barcelona), Spain

 Innovation Department, Hospital Sant Joan de Déu de Barcelona, Esplugues de Llobregat (Barcelona), Spain

Alonso-Arroyo A:
 Department of History of Science and Documentation, University of Valencia, Valencia, Spain

 Information and Social and Health Research (UISYS), University of Valencia, Associated Unit of the Research Institute for Higher Education and Science (INAECU-UC3M-UAM), Valencia, Spain

Tejedor-Romero L:
 Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines and Healthcare Products Agency, Madrid, Spain

Turrini M:
 Institute of Public Goods and Policies (IPP), Centre for Human and Social Sciences, Spanish National Research Council (CSIC), Madrid, Spain

Sandonís-Camarero D:
 Preventive Medicine Service, University Hospital Complex of Salamanca, Salamanca, Spain

Lucas-Domínguez R:
 Department of History of Science and Documentation, University of Valencia, Valencia, Spain

 Information and Social and Health Research (UISYS), University of Valencia, Associated Unit of the Research Institute for Higher Education and Science (INAECU-UC3M-UAM), Valencia, Spain

 Centre for Biomedical Research in Cancer (CIBERONC), Institute of Health Carlos III, Madrid, Spain

Ridao M:
 Data Science for Health Services and Policy Research, Aragon Health Sciences Institute (IACS), Zaragoza, Spain

 Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Institute of Health Carlos III, Madrid, Spain

C Tricco A:
 Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada

 Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

Staniszewska S:
 Warwick Medical School, University of Warwick, Coventry, United Kingdom

Moher D:
 Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

 School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
ISSN: 02139111





Gaceta Sanitaria
Editorial
ELSEVIER, 685 ROUTE 202-206, BRIDGEWATER, NJ 08807, España
Tipo de documento: Article
Volumen: 40 Número:
Páginas: 102591-102591
WOS Id: 001754470900001
ID de PubMed: 42019127
imagen Green Accepted, gold

MÉTRICAS